Active Pharmaceutical Ingredient (Generic)

ATEZOLIZUMAB

🩺 ANTINEOPLASTICS 💊 1 Marketed Brands
Clinical Profile:

*Locally advanced or metastatic urothelial carcinoma (monotherapy), Locally advanced or metastatic non-small cell lung cancer (NSCLC) after prior chemotherapy (monotherapy):* BY IV INF: Adults: The recommended dose is 1,200 mg administered intravenously every three weeks. Consult product literature....

Marketed Brands Containing ATEZOLIZUMAB (1) Compare Brand Prices
Brand Name Manufacturer / Company Available Pack Sizes & Price Action
TECENTRIQ 🏢 ROCHE
Inj 1200 mg/20 ml 1 vial: Rs.355000.00
View Details →